Turner syndrome by Han Jin

Description

hxjin — 2024-10-08 19:09:09 UTC

a chromosomal disorder that affects only females, resulting from the complete or partial absence of one of the X chromosomes (45, X karyotype).

Common symptoms include short stature, delayed puberty, infertility, heart defects, and certain learning disabilities, particularly in spatial reasoning or mathematics.

Despite these challenges, individuals with Turner syndrome can have normal intellectual development. Life expectancy is slightly reduced, primarily due to associated medical conditions such as cardiovascular diseases.

Mutation/gene that causes the disease

hxjin — 2024-10-08 19:11:03 UTC

Turner syndrome is not inherited in a traditional sense, as it is caused by a random chromosomal anomaly. It results from a complete or partial loss of one of the X chromosomes during early fetal development. In most cases, this occurs randomly, with no familial transmission. The absence of an X chromosome (monosomy X) affects gene expression, leading to the physical and medical characteristics seen in the condition.

Importance of understanding the disease

hxjin — 2024-10-08 19:11:09 UTC

Understanding Turner syndrome is essential for early diagnosis and management, which can significantly improve quality of life. Early intervention with hormone therapies (growth hormone and estrogen replacement) can help mitigate symptoms like short stature and delayed puberty. Moreover, awareness of the risks of associated conditions (like heart defects) allows for better monitoring and preventive care, reducing the risk of complications.

Prevalence of the disease

hxjin — 2024-10-08 19:11:20 UTC

Turner syndrome occurs in approximately 1 in every 2,000 to 2,500 live female births globally. It is one of the most common chromosomal abnormalities in females. Many affected pregnancies result in miscarriage, contributing to the relatively lower prevalence in live births.

Any known methods of testing and/or treatment

hxjin — 2024-10-08 19:11:32 UTC

Diagnosis of Turner syndrome can be made prenatally through genetic testing such as amniocentesis or chorionic villus sampling, which detect chromosomal abnormalities. Postnatal diagnosis is typically confirmed through a karyotype analysis, a blood test that identifies the missing X chromosome. Treatment is largely symptomatic and supportive:

Growth hormone therapy is often prescribed to increase height.
Estrogen replacement therapy is used to initiate puberty and support reproductive health.
Ongoing medical care is needed to monitor heart, kidney, and thyroid function.
Assisted reproductive technologies (ART) may be required for women who wish to have children.

Current study 1- A Review of Recent Developments in Turner Syndrome Research

hxjin — 2024-10-08 19:11:46 UTC

Turner syndrome is a rare genetic disorder caused by the complete or partial loss of the second sex chromosome, leading to various symptoms such as delayed growth, premature ovarian failure, heart defects, and other health issues. The condition increases the risk of early mortality, mainly due to cardiovascular abnormalities. There is considerable variability in how Turner syndrome presents in individuals, with no consistent link between the chromosomal makeup and the physical manifestations. Recent research has focused on understanding the underlying genetic and molecular mechanisms, particularly those related to cardiovascular issues. Advances in genomic and epigenetic technologies are helping to uncover the complexities of the syndrome, which may lead to improved treatment and management in the future.

pertinent information

hxjin — 2024-10-08 19:12:02 UTC

Psychosocial support is crucial for individuals with Turner syndrome. While cognitive development is typically normal, some may face challenges in social interaction and learning difficulties, which benefit from tailored educational plans and counseling. Fertility treatments, including the use of donor eggs, can also be a sensitive issue requiring psychological support.

Works Cited

hxjin — 2024-10-08 19:12:28 UTC

Claus H Gravholt, Mette Viuff, Jesper Just, Kristian Sandahl, Sara Brun, Janielle van der Velden, Niels H Andersen, Anne Skakkebaek, The Changing Face of Turner Syndrome, Endocrine Reviews, Volume 44, Issue 1, February 2023, Pages 33–69, https://doi.org/10.1210/endrev/bnac016
Huang, A. C., Olson, S. B., & Maslen, C. L. (2021). A Review of Recent Developments in Turner Syndrome Research. Journal of cardiovascular development and disease, 8(11), 138. https://doi.org/10.3390/jcdd8110138

Responses

hxjin — 2024-10-08 19:12:45 UTC

Current Study 2-The Changing Face of Turner Syndrome

hxjin — 2024-10-08 19:40:45 UTC

In recent years, it has become clear that the treatment of patients with Turner syndrome (TS) requires a multidisciplinary approach. This article reviews several clinical advances and discusses the latest research results on the genomic structure of Turner syndrome. The study presents multiple candidate genes, genomic pathways, and mechanisms, including changes in the transcriptome and epigenome, further deepening the understanding of the disease.